Loading...

MorphoSys AG

MOR•NASDAQ
Healthcare
Biotechnology
$18.96
$0.45(2.43%)

MorphoSys AG (MOR) Stock Overview

Explore MorphoSys AG’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 67.0/100

Key Financials

Market Cap2.9B
P/E Ratio-11.68
EPS (TTM)$-1.50
ROE-1.84%
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 MonthsN/A
1 Year Target$50.81

MOR Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of MorphoSys AG (MOR) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $50.81.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -11.68 and a market capitalization of 2.9B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;